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Mycobacterium tuberculosis is an adaptable intracellular
pathogen, existing in both dormant as well as active disease-
causing states. Here, we report systematic proteomic analyses of
four strains, H37Ra, H37Rv, and clinical isolates BND and JAL,
to determine the differences in protein expression patterns that
contribute to their virulence and drug resistance. Resolution of
lysates of the four strains by liquid chromatography, coupled to
mass spectrometry analysis, identified a total of 2161 protein
groups covering 54% of the predicted M. tuberculosis pro-
teome. Label-free quantification analysis of the data revealed
257 differentially expressed protein groups. The differentially
expressed protein groups could be classified into sevenK-means
cluster bins, which broadly delineated strain-specific variations.
Analysis of the data for possible mechanisms responsible for
drug resistance phenotype of JAL suggested that it could be due
to a combination of overexpression of proteins implicated in
drug resistance and the other factors. Expression pattern analy-
ses of transcription factors and their downstream targets dem-
onstrated substantial differentialmodulation in JAL, suggesting
a complex regulatory mechanism. Results showed distinct vari-
ations in theprotein expressionpatterns ofEsx andmce1operon
proteins in JAL and BND strains, respectively. Abrogating
higher levels of ESAT6, an important Esx protein known to be
critical for virulence, in the JAL strain diminished its virulence,
although it had marginal impact on the other strains. Taken
together, this study reveals that strain-specific variations in pro-
tein expression patterns have a meaningful impact on the biol-
ogy of the pathogen.
The ability of a pathogen to survive under harsh conditions
within the host is connected to its ability to modulate host cel-
lular processes to its advantage. The advent of multiple drug-
resistant and extensive drug-resistantMycobacterium tubercu-
losis strains is a major global heath concern, compromising the
existing therapy (1–3). Despite the best efforts, themechanisms
underlying the pathogenesis, virulence, and persistence of M.
tuberculosis infection associated with the drug-resistant strains
is not very well understood. The identification of virulence fac-
tors that are required for disease progression is critical for
understanding the biology of infection.
The availability of whole genome sequences of different M.
tuberculosis strains (4–6) has enabled genome-wide compari-
sons to identify the presence of deletions or genemutations that
correlate with virulence (7). In recent years systems biology
approaches, which study complex interactions, have been suc-
cessfully applied to predict the networks and dynamic interac-
tions between pathogen and host (8, 9). Various genome-wide
studies comparing drug-sensitive and drug-resistantMycobac-
terium strains have identified multiple single nucleotide poly-
morphisms related to DNA repair, replication, and recombina-
tion genes, thereby providing insights into the genetic basis of
drug resistance (10–13). Transcriptomics analyses of multiple
drug-resistant strains in comparisonwith drug-sensitive strains
have highlighted the role of altered gene expression of type II
fatty-acid synthases, efflux genes, central metabolic pathway
members, ABC transporters, and genes related to stress
response (14–17).
Quantitative protein expression profiling has proven to be a
useful method in understanding how mycobacterial species
adapt to different stress conditions. Previous studies have uti-
lized differential growth conditions in vitro tomimic stress con-
ditions and have identified cellular markers for these stress
conditions with the help of two-dimensional gel electrophore-
sis-based approaches (18–21). Two-dimensional gel electropho-
resis-based approaches have also been used to identify strain-
specific differences among virulent and avirulent strains of M.
tuberculosis (18, 19, 22, 23). With advances in technology, dif-
ferential proteomic analysis has emerged as a valuable tool in
generating large datasets to elucidate complex biological sys-
tems (24–26). Quantitative proteomics studies have high-
lighted differential expression of proteins amongM. tuberculo-
sis strain H37Rv andMycobacterium bovis BCG, particularly in
relation to lipid biosynthesis pathways (18, 27) as well as during
different phases of growth and nutrient starvation (28, 30). In a
related study, quantitative proteomic analysis with the help of
dimethyl labeling was utilized to investigate the carbon assim-
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ilation process inMycobacterium smegmatis (31). Using a com-
bination of discovery and targeted approaches, a selected reac-
tion monitoring-based M. tuberculosis proteome library was
recently generated to accurately quantitate the proteins of M.
tuberculosis and related clinical strains (32). Despite several
reports regarding the M. tuberculosis proteome, very few pro-
teomic studies have been performed on drug-resistant clinical
strains (33).
Although efforts have been focused on identifying secreted
as well as intracellular mycobacterial proteins, less attention
has been paid toward comparing the protein profiles of clinical
isolates with commonly used laboratory-adapted strains such
as H37Rv. This report details the results of a systematic whole
cell proteome analysis of the laboratory avirulent strain H37Ra,
laboratory virulent strain H37Rv, single drug-resistant clinical
isolate BND-433, and multidrug-resistant clinical isolate
JAL-2287.
Materials andMethods
Bacterial Growth Conditions—All the bacterial strains
(H37Rv (Rv), H37Ra (Ra), BND-433 (BND), and JAL-2287
(JAL)) used in the studywere grown inMiddlebrook 7H9media
(Difco) supplemented with 0.2% (v/v) glycerol, 10% albumin
dextrose/catalase, and 0.05%Tween 80 at 37 °C. Cells were har-
vested at middle-late log phase (A600 1–1.5), and bacterial
pellets were washed twice with TBST (20mMTris-HCl, pH 7.5,
150 mM NaCl, 0.1% Tween 20) and once with TBS (20 mM
Tris-HCl, pH 7.5, 150 mM NaCl) and stored at80 °C.
To monitor the growth of mycobacteria in different growth
media, 10  106 bacteria/ml for each strain were washed with
PBS (20mMphosphate buffer, pH 7.4, 150mMNaCl) and added
to two different carbon source (0.05% oleic acid or 0.05% cho-
lesterol)-supplemented 7H9 growth media formulations. Ala-
mar Blue (0.01%) (Life Technologies, Inc.) was added to these
cultures, and the reduction of Alamar Bluewasmonitored from
0 to 30 h by measuring the absorbance according to the man-
ufacturer’s instructions.
Sample Preparation—Cell pellets were resuspended in lysis
buffer (8 M urea in 25 mM ammonium bicarbonate) supple-
mented with complete protease and phosphatase inhibitor
mixture (Roche Applied Science). The cells were lysed within a
bead beater with the help of 0.1-mm zirconium beads. The cells
were disrupted in a Mini bead-beater for 10–12 cycles (45-s
pulse with 60-s incubation). Lysates were clarified by centrifu-
gation, and the concentrations were determined by the Brad-
ford assay (Bio-Rad).
50 g of the sample was first reduced with 5 mM tris(2-
carboxyethyl)phosphine and further alkylated with 50 mM
iodoacetamide. The samples were diluted to 1 M final urea con-
centration with 25 mM ammonium bicarbonate buffer and
digested with trypsin (1:50, trypsin/lysate ratio) for 16 h at
37 °C. Digests were cleaned using a C18 silica cartridge (The
Nest Group, Southborough, MA) according to the manufactu-
rer’s protocol and dried using a speed vac. The dried pellet was
resuspended in buffer A (5% acetonitrile, 0.1% formic acid).
Mass Spectrometric Analysis of Peptide Mixtures—All the
experiments were performed using EASY-nLC system
(Thermo Fisher Scientific) coupled to LTQ Orbitrap-Velos
mass spectrometer (Thermo Fisher Scientific) equipped with
nanoelectrospray ion source. 1 g of the peptide mixture was
resolved using a 10-cm PicoFrit Self-Pack microcapillary col-
umn (360-m outer diameter, 75-m inner diameter, 10-m
tip) filled with 5 m of C18-resin (Magic). The peptides were
loadedwith bufferA and elutedwith a 0–40%gradient of buffer
B (95% acetonitrile, 0.1% formic acid) at a flow rate of 300
nl/min for 120 min. This was followed by a 10-min gradient of
40–80%, 20-min gradient of 80–90%, and finally equilibrated
with buffer A for 30 min.
The LTQ Orbitrap-Velos was operated using the Top10
higher energy collisional dissociation (High/High) data-depen-
dent acquisition mode (34) with a full scan in the Orbitrap and
an MS/MS scan in the higher energy collisional dissociation.
The target values for the full scanMS spectrawere set at 1 106
charges with a maximum injection time of 200 ms, and a reso-
lution of 30,000 at m/z 400. MS/MS scans were acquired at a
resolution of 7500 atm/z 400with an ion target value of 1 104
with a maximum injection time of 200 ms. Lock mass option
was enabled for polydimethylcyclosiloxane ions (m/z 
445.120025) for internal recalibration during the run.
Data Processing—Four biological replicates were processed
for each strain, and the 16 RAW files generated were analyzed
with MaxQuant (version. 1.4.1.2) against the M. tuberculosis
UniProt reference proteome database. For Andromeda search,
the precursor and fragmentmass tolerances were set at 10 ppm
and 0.5 Da, respectively. The protease used to generate pep-
tides, i.e. enzyme specificity was set for trypsin/P (cleavage at
the C terminus of “K/R: unless followed by “P”) alongwithmax-
imummissed cleavages value of two. Carbamidomethyl on cys-
teine as fixed modification and oxidation of methionine and
N-terminal acetylation were considered as variable modifications
for database search. The settings also included reverse sequences
of database and in-built 247 contaminants in default settings of
MaxQuant. For peptide identification, a peptide posterior error
probability threshold of 0.05was specified. Both peptide spectrum
match and protein false discovery rate were set to 0.01. Default
settings were applied for all other parameters.
For quantitative comparison among the biological replicates
of the four strains, label-free quantification with “match
between runs” option was utilized within the MaxQuant suite
with standard settings for generating the peak lists from 16 raw
files (Xcalibur and ThermoFisher Scientific) with a retention
time alignment window of 1 min. Protein groups were created
by default settings of MaxQuant in case the peptide sets were
common among multiple proteins. For dynamic range estima-
tion, iBAQ3 analysis was also performed with default settings.
Bioinformatics Analysis—Bioinformatics analysis was per-
formed using Perseus software. UniProt annotation for M.
tuberculosis reference proteome database was utilized for GO
classification of all the identified proteins. Custom-made perl
scripts were utilized for correlating Mycobacterium UniProt
identifiers with tuberculist database protein entries. Z-score
3 The abbreviations used are: iBAQ, intensity-based absolute quantification;
ANOVA, analysis of variance; PCA, principal component analysis; ADH, ala-
nine dehydrogenase; LFQ, label-free quantification; PC. principal compo-
nent; ABC, ATP-binding cassette; PMA, phorbol 12-myristate 13-acetate.
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normalization was performed on the log2 transformed LFQ
values obtained from label-free quantification analysis. The 16
samples were divided into four strain groups, and ANOVA test
was performedwith BenjaminiHochberg correction. ANOVA-
significant proteins were utilized for hierarchical clustering
analysis. Principal component analysis (PCA) was performed
using ggbiplot package in R (3.1.0), whereas K-means clustering
was performed using the Past analysis tool. Different graphics
were generated using a combination of R (3.1.0 version),
Graphpad, and Excel software. The mass spectrometry pro-
teomics data have been deposited to the ProteomeXchange
Consortium (35) via the PRIDE partner repository with the
dataset identifier PXD001188.
ESAT-6 Antibody Treatment—10  106 bacteria for each
mycobacterial strain were washed with PBS and either treated
with ESAT-6 antibody (ab26246) or not treated for 45 min at
room temperature. Untreated and ESAT-6 antibody-treated
cultures were processed for infection of PMA-differentiated
THP-1 cells at a multiplicity of infection of 10. Infection was
maintained at 37 °C in aCO2 incubator for 4 h followed by 2 h of
amikacin treatment to remove any extracellular bacteria.
Infected cells were washed with RPMI 1640 medium followed
by lysis using 0.06% SDS and plated on 7H11 agar plates to
determine the CFUs. 15 days post-plating CFUs for each strain
were counted and averaged between multiple sets.
Results
Proteome Analysis of Virulent and Avirulent M. tuberculosis
Strains—BND-433 and JAL-2287 strains are CAS clade clinical
strains that are resistant either to only streptomycin or strepto-
mycin, isoniazid, and rifampicin, respectively (36). Prior to pro-
teomic analysis of the four strains, we monitored their growth
profiles in 7H9 medium every 24 h over 8 days. The growth
profiles for all four strains were found to be similar until day 5
(Fig. 1A). To perform comparative proteomics analysis, cells
were harvested on day 3, and four biological replicates for each
strain were processed using the proteomic workflow shown in
Fig. 1B. The raw files were searched against UniprotM. tuber-
culosis reference proteome database, and a total of 2161 protein
groups were identified with high confidence using 1% protein
and peptide false discovery rate cutoff (supplemental Tables
1–3). The identified proteins covered54%of the predictedM.
tuberculosis proteome, with each run identifying between 1700
and 1900 protein groups (Fig. 1C). Comparative analysis of the
protein groups of Rv, Ra, BND, and JAL strains revealed 13, 12,
13, and 22 strain-specific protein groups, respectively (Fig. 1D).
Among them 3, 2, 3, and 18 protein groups were detected in at
least two biological replicates of the particular strain, respec-
tively, and not in the others (supplemental Table 4).
To categorize proteins according to their functional rele-
vance, we first organized theM. tuberculosis database proteins
(a total of 4031 proteins) into functional categories as per the
tuberculist classification (Fig. 1E). The highest numbers of pro-
teins were conserved hypotheticals, cell wall and cell pro-
cess-related, and those involved in intermediary metabolism and
respiration (Fig. 1E). The 2161 proteins identified in the proteome
as part of this study were distributed over all the functional cate-
gories,with themajorityof theproteinsbelonging to thecategories
of intermediary metabolism and respiration (31%), conserved
hypotheticals (22.2%), and cell wall and cell process-related
(17.2%), constituting66% of the total identified proteome.
Relative Protein Quantification—To estimate the abundance
of identified proteins, iBAQ was carried out using MaxQuant
software package. This method takes into consideration the
summation and normalization of MS signals based on peptide
size, length, and number of theoretical peptides possible for all
the proteins identified in a particular proteome run (26, 37).
The iBAQ intensity in the composite proteome spanned a
dynamic range of 6 orders of magnitude between the most and
least abundant proteins (Fig. 2 and supplemental Table 5). The
most abundant proteins thus identified were chaperones, elon-
gation factors, ribosomal proteins, chromosomal architectural
proteins, and secretory proteins. Many of these protein fami-
lies, such as heat shock proteins (including chaperones), ribo-
somal proteins, and ribosomal translational machinery, are
highly expressed in several organisms, including mycobacterial
species (37, 38). Plotting all the identified proteins on the iBAQ
protein abundance scale indicated that the majority of strain-
specific proteins (supplemental Table 5) were present in the
low abundance range. However, some JAL-specific proteins
were found in the moderate abundance range.
LFQ methodology was used to compare the levels of identi-
fied proteins among the four strains (39). To cross-compare the
reproducibility of results across the biological replicates, a cor-
relation matrix was generated (data not shown). The Pearson
correlation of 0.8–0.9 among the biological replicates sug-
gested low variance and high reproducibility, and these multi-
ple scatterplots also showed a larger spread of LFQ values in the
inter-strain comparison. Among the 2161 proteins identified in
the composite proteome, we were able to quantify 1348 pro-
teins after application of LFQ (Fig. 3A; quantification values
from 16 samples; minimum row filter 8). Further box plots
generated after Z-score median normalization of these 1348
proteins also showed high reproducibility among the biological
replicates (data not shown).
Proteome of the JAL Strain Is Significantly Different from Ra,
Rv, andBND—To investigate differential expression among the
four strains, we applied Benjamini-Hochberg correction for
multiple hypotheses testing using one-way ANOVA test with a
cutoff value of 0.05 (Fig. 3A). Among the 257 differentiallymod-
ulated proteins (supplemental Table 6), a majority of the pro-
teins belonged to categories of intermediary metabolism and
respiration (33%), lipid metabolism (17.1%), cell wall and cell
process-related (14%), and conserved hypotheticals (14%), with
10% belonging to the category of information processing
pathways (Fig. 3B). The supplemental Table 7,A and B shows a
summary of statistical variations among the biological repli-
cates in the 257 ANOVA significant protein groups. These 257
protein groups were further subjected to unsupervised hierar-
chical clustering, and the resulting clustergram is shown in Fig.
3C (left panel). Scrutiny of the clustergram indicated that the
large numbers of proteins are either up- or down-regulated in
the JAL strainwhen comparedwith the remaining three strains.
The two major clusters of proteins displaying prominent up-
and down-regulation in the JAL strain were further arranged as
profile plots (Fig. 3C, right panel).
Strain-specific Protein Expression Profiles inM. tuberculosis
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FIGURE 1. Proteome analysis of virulent and avirulentM. tuberculosis strains. A, in vitro growth analysis of mycobacterial strains H37Ra, H37Rv, BND, and
JAL in 7H9medium.All the cultureswere seededat an initialA600 of 0.05, andgrowthwasmonitoredevery 24h for 7days.B, schematic illustrationof thedesign
and workflow to perform the quantitative proteomics analysis across the four Mycobacterium strains. Cell pellets were lysed with 8 M urea/AB-25, and equal
amounts of lysates were trypsin-digested, and the purified peptides were identified using high resolution LC-MS/MS analysis using LTQ Orbitrap Velos
instrument. C, raw MS files were processed with MaxQuant (version. 1.4.1.2) against the M. tuberculosis UniProt reference proteome database. The false
discovery rate was set at 0.01 for both peptides and proteins. Bioinformatics analysis was performed using Perseus software. Custom-made perl scripts were
utilized for correlating Mycobacterium UniProt nomenclature with tuberculist database entries. The table shows the number of proteins identified for each
biological replicate for all four strains. D, the Venn diagram shows the number of unique and common proteins among the four strains. E, pie chart shows the
details of tuberculist classification of functional categories ofM. tuberculosis proteome.
FIGURE 2. iBAQanalysis anddynamic range estimation of identifiedmycobacteriumproteome.A, combined iBAQprotein expression values for the
2157 proteins were plotted with log10iBAQ intensity on the y axis, and proteins were ranked by iBAQ intensity on the x axis. Plot reveals a dynamic range
of 6 orders ofmagnitude (left panel). B, list of ninemost (colored red) and least (colored blue) abundant proteins based on iBAQ intensity. C, strain-specific
protein expression plot based on iBAQ intensities. Rv, Ra, BND, and JAL strain-specific proteins were represented in blue, green, pink, and yellow.
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To validate the results obtained using the above workflow,
we selected CFP-10, ESAT-6, L-ADH, and GroEL1 as test pro-
teins in Western blotting analyses of whole cell lysates.
Although L-ADH (belonging to the category of intermediary
metabolism and respiration) is down-regulated in JAL, the
secretory protein CFP-10 and ESAT6were up-regulated in JAL
(Fig. 4A). TheM. tuberculosis housekeeping proteinGroEL-1, a
primary chaperonin, which showed minimal variations across
the strains, was selected as controls. We found that although
the GroEL1 expression pattern was similar across all the four
strains, L-ADH expression was lower in JAL compared with the
other strains, and CFP-10 and ESAT6 expressions were consid-
erably higher (Fig. 4B). Thus, the expression profiles detected
by Western blots were found to be reasonably consistent with
the results obtained with LFQ quantification, validating our
experimental approach.
In general, the JAL strain displayed substantial differential
regulation of proteins as compared with the other strains
(Figs. 3C and 4, A and B). PCA was performed on the differ-
entially regulated proteome data sets across the strains and
replicates (Fig. 4C). In keeping with the finding that there are
significantly higher numbers of differentially regulated pro-
teins in the JAL strain, on the principal component 2 (PC2)
versus PC1 plot all the JAL replicates clustered diametrically
opposite to the other three strains (Fig. 4C). The first two
principal components were most significant as together they
captured more than 62% of the variations in the data (Fig.
4D). Although each of the Ra and Rv replicates clustered in
FIGURE 3. Relative protein quantification. A, brief overview of data analysis steps. B, Venn diagram showing details of tuberculist classification of functional
categories among the ANOVA-significant proteins. C, left panel, clustergram of the ANOVA-significant 257 proteins differing among the four strains. The
Z-scored normalized abundance values of proteins are represented by red (high abundance) and green (low abundance) colors as indicated in the color scale
bar at the top. The twohighlighted clusters represent proteinswith decreased (green) and increased (red) abundance in the JAL strain. Right panel,profile plots
displaying the low and high abundant clusters of clustergram with respect to the JAL strain.
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the same quadrant, BND replicates clustered in the adjacent
quadrant (Fig. 4C).
We classified the proteins into strain-specific ellipses, encir-
cling molecules with significant projections on respective princi-
pal components.Molecules showing significant projections in JAL
clustered together in the PC2 versusPC1plot alongside its loading
vectors (Fig. 4C). Similarly, molecules showing significant impor-
tance in Ra clustered corresponding to its loading vectors. How-
ever, molecular vectors for Rv and BND were relatively less clus-
tered, spreading to the quadrants enriched with JAL-specific
molecular vectors (Fig. 4C). This was an interesting observation
because the three strains other thanRa are virulent, and it appears
that in keeping with this commonality they share features despite
inherent variations. Interestingly, a set of proteins from the BND
cluster was placed outside the BND ellipse. These belonged to the
mce1operon, consistingof genes involved in the regulationof lipid
metabolism in M. tuberculosis (40). This feature distinguished
BND from the other three strains.
K-means Cluster Analysis—We next performed K-means
cluster analysis on the set of ANOVA-significant 257 proteins.
FIGURE 4. PCA analysis and validation of significant proteins. A, profile plots showing the fold change analysis of selected genes, which were up- or
down-regulated in the JAL strain. The median values obtained for each strain were plotted on the y axis. B,whole cell lysates were estimated with the help of
the BCA assay kit (Thermo). 50 g of whole cell lysates were resolved on SDS-PAGE, transferred to nitrocellulose membrane, and probed separately with
-CFP10,-ESAT6, and-ADHantibodies (Abcam). 7.5gofwhole cell lysateswere used for probingwith-GroEL1 antibody (control).C,biplots of a principal
component analysis performed onmycobacterial cell linesmeasured in quadruplicate.Matlabwas utilized for PCA. The arrows indicate the loadings of the cell
lines (Rv, Ra, BND, and JAL). All 257 ANOVA significant proteins were used in the analysis. D, Parreto’s plot for the principal components (Fig. 3C). Fractions of
variability in the data captured by each of the principal components are shown here as bars. The cumulative variance captured by the principal components
is represented as the line. Note that first two principal components together account for more than 70% of the variance.
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K-cluster typically brings proteins having a similar expression
pattern together and allows functional enrichment analysis to
understand the consequences of the observed expression pat-
tern. We decided to use seven bins for the K-cluster analysis,
partly based on empirical observation of distinct clusters in the
clustergram shown in Fig. 3C. The K-bin specific expression
patterns of constituent proteins are shown in Fig. 5 and
supplemental Table 8. Analysis of cluster-specific profiles
revealed interesting patterns. For example, all the 45 proteins
(supplemental Table 8A) present in cluster 1 were up-regulated
in JAL and down-regulated in the other three strains (Fig. 5).
Proteins in clusters 2 and 5 showed prominent down-regula-
tion in H37Ra. Although we observed a significant up-regula-
tion of proteins in JAL in cluster 2, in cluster 5 a comparable
expression of proteins was observed in JAL, BND, and Rv. Clus-
ter 3 contained 17 proteins, which specifically showed lower
expression in BND compared with the other three strains (Fig.
5). Both clusters 4 and 6 showed down-regulation of proteins in
the JAL strain. Proteins present in cluster 4 showed the highest
expression in Ra andmoderate expression in Rv strain, with low
expression in BND and lowest in JAL strain (Fig. 5).
Next, we addressed the question of whether strain-specific
clusters were also enriched in proteins of specific functional
categories. Fig. 6A shows classification of proteins present in
each of the seven clusters into different functional classes. The
percentage distribution of these functional categories is shown
FIGURE 5. K-means cluster analysis of ANOVA-significant proteins. A, proteins showing significant protein abundance changes were grouped into seven
clusters.MedianofZ-scored log2normalizedvalues for eachquadruplicatewasused for cluster analysis.Matlabwasutilized for K-means clustering.B, bar chart
showing the number of protein in each cluster.
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in Fig. 6A. This analysis yielded a few puzzling revelations. For
example, cluster 5, whose proteins showed significant down-
regulation in JAL comparedwith other strains, had amaximum
number of genes belonging to lipid metabolism, intermediary
metabolism, and hypoxia, which are considered to be critical
for improved survival of pathogen in host (41). In contrast, cell
FIGURE 6.Distribution among theK-mean clusters.A, bar chart showing the percentage of tuberculist functional categories present in each cluster. B and C,
metabolic pathway for the -oxidation of fatty acids. B, clustergram of the 12 differentially expressed proteins across the four M. tuberculosis strains in the
subsystem -oxidation of fatty acids. The Z-scored normalized abundance values of proteins are represented by red (high abundance) and green (low
abundance) colors. C, -oxidation of fatty acids is accomplished by four enzyme-catalyzed reactions as given in the outline. This pathway is highly redundant
at the level of genes encoding the associated enzymes for the four reactions. In the M. tuberculosis genome, there are 35 predicted genes for acyl-CoA
dehydrogenase, 22 predicted genes for enoyl-CoA hydratase, 4 predicted genes for L-3-hydroxyacyl-CoA dehydrogenase, and 6 predicted genes for -keto-
thiolase (indicated). The differentially expressed genes in the -oxidation pathway across the fourM. tuberculosis strains are indicated in blue.
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wall-related proteins in clusters 1 and 2 were up-regulated in
JAL. Notably, we observed that seven members of the Esx fam-
ily were also part of clusters 1 and 2 (Fig. 5 and supplemental
Table 8A). Surprisingly, we observed only 10 protein groups
among the 257 that have shown similar expression patterns
between JAL and BND strains (supplemental Table 8B). We
also observed the down-regulation of themce1 operon proteins
in cluster 3, in the single drug-resistant BND strain in compar-
ison with other strains, suggesting a possible compromise in
lipid homeostasis. Thus K-cluster analysis provided a glimpse
of the strain-specific protein profile variations, which can be
used to address the differential behavior of these strains in
terms of virulence, survival, and drug resistance.
Metabolic Network Analysis—From the list of enriched func-
tional categories across the 257 differentially expressed protein
groups reported in Fig. 2B, it was evident that a significant frac-
tion of differentially expressed proteins aremetabolic enzymes.
Thus, we decided to overlay the set of differentially
expressed proteins onto the most recent genome-scale met-
abolic network reconstruction iOSDD890 for M. tuberculo-
sis (42). We found that 90 out of the 257 differentially
expressed proteins were enzymes catalyzing reactions in the
metabolic model iOSDD890, and these 90 differentially
expressed enzymes participate in reactions that belong to 29
different subsystems or metabolic pathways (supplemental
Table 9). From the classification of the 90 differentially
expressed enzymes into different subsystems of the metabolic
network (supplemental Table 9), we find that 5 out of 7 differ-
entially expressed proteins in the subsystem “membrane
metabolism” and 4 out of 5 differentially expressed proteins in
the subsystem “redox metabolism” are up-regulated in the JAL
strain (supplemental Table 9).
Moving onto the lipid metabolism, there are 12 differentially
expressed proteins across the fourM. tuberculosis strains in the
subsystem “-oxidation of fatty acids” (supplemental Table 9
and Fig. 6B), of which only one protein is down-regulated in Rv
strain, but six proteins were down-regulated in the JAL strain.
At first glance, from the comparative analysis of the total num-
ber of down-regulated proteins in the -oxidation pathway
across strains, it may seem that this pathway for utilization of
fatty acids is down-regulated in JAL compared with Rv (they all
belong to cluster 6 in Fig. 5). But the -oxidation pathway is
highly redundant with several genes in the M. tuberculosis
genome encoding each of the four enzymes catalyzing the four
reactions in the subsystem (Fig. 6B), and any conclusions on
differential activity of this pathwaymust be drawn in the light of
the underlying redundancy in the system. On closer examina-
tion, we found that although six differentially expressed pro-
teins in the -oxidation pathway were down-regulated in the
JAL strain, therewas at least one protein associatedwith each of
the four reactions in the pathway that was up-regulated in the
JAL strain (Fig. 6B). Thus, by properly accounting for the
redundancy in the -oxidation pathway, we find that this path-
way is not down-regulated and compromised in JAL strain.
Differential Modulation of Transcription Factors and Their
Targets May Contribute to the Virulence of JAL—As the data
presented in Figs. 4 and 6A revealed that in general the protein
expression was most differentially regulated in JAL among the
strains being studied here.We considered the possibility of this
occurring via the enhanced/reduced expression of specific
transcription factors, which would result in an increased/de-
creased activation of the specific target genes. Thus, we sought
to investigate the expression patterns of transcription factors
and their downstream targets among the ANOVA-significant
proteins. Toward this, we superimposed the expression data of
the 257 differentially expressed proteins on two recently
reported gene regulatory networks of M. tuberculosis (43, 44).
Analysis revealed a total of 12 of these to be transcription fac-
tors, with seven being present in both the networks. Among the
12, seven transcription factors are up-regulated and five are
down-regulated specifically in the JAL strain (Fig. 7A).With the
exception of transcription factors Rv3139c, Rv2989 and
Rv3597c, we have either not found any or found only one or two
targets for the remaining transcription factors among the 257
protein groups. Among the down-regulated transcription fac-
tors, the downstream targets of only one (Rv3139c/DosR) were
found to be present in the galagan network (43), and these were
also down-regulated in JAL (Fig. 7D). Among the up-regulated
transcription factors the downstream targets of only two,
Rv2989 and Rv3597c (Lsr2), were a part of the group of 257
proteins. Among the eight downstream targets of Rv2989,
seven were found to be significantly up-regulated in JAL
although one showed relatively higher expression compared
with Rv. Interestingly, in the case of Lsr2 we observed a mixed
pattern. At least 38 of the 601 targets of Lsr2 were either up- or
down-regulated in JAL. Lsr2 is known to be a transcriptional
repressor, and this mixed expression pattern observed signifies
the interplay of complex regulatory mechanisms. The overall
expression patterns of these transcription factors and their cor-
responding targets are consistent with previous reports
(45–48).
Distinct Variations in Expression of Esx Contributes to the
Survival Fitness of JAL—Analysis of the data presented in Figs. 4
and 5 suggested lower expression of the entire mce1 operon
consisting of genes involved in the regulation of lipid metabo-
lism inM. tuberculosis in the BND strain (Fig. 8A). This feature
distinguished BND from the other three strains. Analysis of the
257 ANOVA-significant proteins showed that 10 proteins cor-
responding to the Esx family are up-regulated in JAL compared
with the other three strains (Figs. 5, cluster 1, and 8B). Esx pro-
teins are known to be critical for virulence, and their higher
expression could be linked to the higher virulence of the JAL
strain. Because the analysis was performed with the whole cell
lysates, we sought to determine the levels ofCFP10, ESAT6, and
ADH in the culture filtrate fractions. Aswas the casewithwhole
cell lysates (Fig. 4, A and B), ADH levels were observed to be
lower in the culture filtrate fraction of JAL compared with the
other strains (Fig. 8C). In agreementwith the analysis, the levels
of CFP10 in the culture filtrate fraction of JAL were found to be
significantly higher (Fig. 8, B and C). However, in the case of
ESAT6, an additional band migrating above the ESAT6 band
was observed in the JAL lane (Fig. 8C), which could be due to
some form of post-translational modification. To confirm the
identity of the additional band in a separate experiment, we
aligned the membrane with the Western blot, and both the
bands were excised separately from the membrane. Mass spec-
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trometry analysis of the tryptic peptides obtained from the
membrane identified ESAT6 as the major protein in both the
bands (60% coverage; five peptideswere identified in each case),
thus confirming the identity (data not shown). Consistent with
the analysis (Fig. 8B), combined intensities of both the bands of
ESAT6 in the JAL sample was higher compared with the other
strains. Next, we sought to analyze whether the elevated levels
of Esx proteins in JAL provide any survival advantage. Toward
this, we performed ex vivo infections (THP1 cells) with all the
strains and examined their survival post-infection. As expected,
the Ra strain showed compromised survival. Although BND
showed marginally compromised survival at the 24-h time
point, the overall trend of survival in the differentiated profile
was very similar to Rv. In contrast, the JAL strain seems to have
considerable advantage in the host at every time point (Fig. 8D).
Consistent with these results, we observed higher bacillary
count, even at 6 h post-infection, in comparison with the other
three strains in THP-1 cells infected with JAL strain (Fig. 8E). If
the higher bacillary count observed in JAL were to be due to
higher levels of secretory proteins such as ESAT-6, then
decreasing ESAT-6 levels could be expected to compromise the
bacillary count. Although pre-incubation of the bacteria with
ESAT-6 antibody did not significantly alter the bacillary load in
other strains, we observed an 2.5-fold decrease in the bacil-
lary load in the JAL strain (Fig. 8E).
PossibleMechanisms for Drug Resistance—Drug resistance in
M. tuberculosis can arise either due tomodifications in the per-
meability barrier, up-regulation in the expression of efflux
pump proteins, or genetic alterations of the target site in the
target proteins (49). BND strain is resistant to streptomycin,
and JAL strain is resistant to streptomycin, isoniazid, and rifam-
picin (36). To determine the relevance of known efflux pump
proteins in the drug resistance, we looked at the 257 ANOVA-
significant protein groups for their presence. With the excep-
tion of Rv1410c (50), a known drug efflux pump protein, and
Rv2564, a hypothetical protein with ABC-like cassette, we did
not find any other proteins with a transporter function. Both
these proteins are down-regulated in JAL2287 butmostly unaf-
fected in the other three strains thus omitting the possibility of
their involvement.
To gain further insights into the possible mechanisms for
drug resistance phenotypes, we mined the literature for candi-
dates that have been up- or down-regulated in drug-resistant
strains. We limited our analysis to proteins that are associated
with streptomycin, isoniazid, and rifampicin resistance among
the 257ANOVA-significant protein groups. Unfortunately, the
FIGURE 7. Protein levels of transcription factors vary among the strains. A, profile plots showing the fold change of different transcription factors found
among the 257 ANOVA-significant proteins. B, Galagan network analysis of transcriptional factors. C, profile plots showing the fold change of the target
proteins, whose expression is regulated by Lsr2. D, profile plots showing the fold change of the target proteins whose expression is regulated by R2839.
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protein expression patterns for the streptomycin resistance
phenotype of the BND strain did not comply with the existing
literature (Table 1). Thus, we speculate that in case of the BND
strain, the resistance could be due to the genetic alterations or
modifications in the permeability barrier. The data (Table 1)
could be broadly divided into two groups. In the first group, the
previous observations in terms of regulation of a candidate pro-
tein were contrary to the protein levels observed in the multi-
drug-resistant JAL strain. These include the ABC transporter/
efflux pump proteins, Rv3028 and Rv2933 (23, 50, 51). Rv2933
FIGURE 8.Protein levels of Esx andMceproteins vary among the strains.A,profile plots showing the fold changes betweendifferentM. tuberculosis strains
for the Mce proteins. B, profile plots showing the fold changes of different ESX pathway proteins (among the 257 proteins) between the four mycobacterial
strains. C, culture filtrate fraction for each strain was estimatedwith the help of BCA assay kit. 15g of culture filtrates were resolved on SDS-PAGE, transferred
to nitrocellulose membrane, and probed separately with -CFP10, -ESAT6, and -ADH antibodies. D, THP1 cells differentiated with PMA were infected with
Rv, Ra, BND, and JAL strains, andCFUswere enumeratedat different timepoints post-infection. TheCFUs at different timepoints for each strainwere calculated
with respect to the CFUs obtained at 0 h, which was normalized to 100. The experiment was performed in triplicate. and error bars represent S.E. E, uptake
compromised with ESAT-6 antibody treatment. M. tuberculosis cultures were treated with ESAT-6 antibody (ESAT 6) for 45 min at room temperature.
Post-treatment, the cultures were washed and processed for infecting PMA-differentiated THP-1 cells at a multiplicity of infection of 10:1. As a control,
untreatedM. tuberculosis cultures were used. After 6 h post-infection, the cells were lysed and plated for obtaining CFU. The data represent average of values
from three separate experiments.
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was identified to be up-regulated in a proteomic analysis of wild
type and rifampicin-resistant Beijing clinical strains (52).
Although we noticed up-regulation of Rv2933 in JAL and BND
compared with Rv strain, its levels were much higher in rifam-
picin-sensitive Ra strain (Table 1). In the second group, the data
from the literature were in agreement with the protein levels
observed in JAL strain (Table 1). The quantitative proteomic
analysis streptomycin-resistant isolates ofM. tuberculosis have
shown decreased expression of Rv0824 and Rv3133 (DevR)
(53). Down-regulation of DevR has also been implicated in the
hypervirulence of M. tuberculosis resulting in early death of
SCID mice (54). Interestingly, we observed significant down-
regulation of Rv0824 and DevR in the JAL strain, which may
explain streptomycin resistance as well as hypervirulence phe-
notypes. Proteomic analysis of streptomycin- or isoniazid-re-
sistant strains has revealed up-regulation of a number of pro-
teins (23, 51). Few among these proteins such as Rv2145c,
Rv1240, Rv2971, Rv0560c, and Rv1446c were significantly up-
regulated in the JAL strain (Table 1). Isoniazid was shown to
induce the expression of propionyl-CoA carboxylase -chain 6
(Rv2247) (15). Similarly, overexpression of isoniazid-induced
protein (Rv0341-IniB) led to prolonged survival of an otherwise
sensitive strain ofM. tuberculosis even at an inhibitory concen-
tration of isoniazid (55). Both of these proteinswere found to be
up-regulated in JAL compared with the other strains. Taken
together, the isoniazid and streptomycin resistance phenotype
of JAL strain could be due to the overexpression of multiple
candidate proteins (Table 1). However, we have not found any
such correlation for rifampicin resistance phenotype of JAL,
which could either be due to altered permeability or genetic
alterations. Thus we speculate that the multidrug resistance
phenotype of JAL could be due to a combination of overexpres-
sion of proteins implicated in drug resistance (Table 1), genetic
alterations, and/or altered permeability.
Discussion
Here, we report a comprehensive analysis of the proteomes
of four different strains of Mycobacterium that are avirulent
laboratory strain, virulent laboratory strain, single drug-resis-
tant clinical isolate, and multidrug-resistant clinical isolate,
respectively. The depth of coverage of54%was achieved with
a fairly simple proteomic workflow in a single run that did not
involve labeling or pre-fractionation of peptides. Correlation
analysis of the four biological replicates of each strain showed
R-values greater than 0.82, confirming their suitability for fur-
ther statistical analysis. Utilization of label-free quantification
methodology to discover strain-specific proteomic differences
revealed that 257 protein groups were differentially expressed
among the four strains.
K-means cluster analysis of the 257 proteins suggested seven
distinct expression patterns. Cluster 1 contained proteins such
as RegX1 (Rv0491), a constituent of the two-component regu-
latory system, as well as Rv2971 (probable oxidoreductase) that
are highly expressed in isoniazid-resistant M. tuberculosis
strains (23). Other interesting candidates were HtrA, serine
protease (Rv1223; previously reported to be a major virulence
factor of Streptococcus pneumoniae in an in vivo pneumonia
model (56–58)), and KasB (Rv2246; causes subclinical latentTA
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tuberculosis in immunocompetentmice (59–61)).Many of the
proteins in the clusters 2 and 5 are related to ribosome biogen-
esis and energy generation. Rv1446 (OpcA) and Rv2145c
(Wag31; plays a role in peptidoglycan synthesis and regulating
cell shape and oxidative response) that are expressed in higher
levels in isoniazid-resistant strains are part of cluster 2 (23, 62,
63). The higher expression of these proteins in JAL compared
with the other strains is consistent with itsmultidrug resistance
and implicates a role for these proteins in mediating cell sur-
vival under stress.
Interestingly, virulence-related proteins, such as Rv2780
(L-alanine dehydrogenase), Rv0126 (TreS), Rv2299c (HtpG),
two-component system proteins like Rv0042c, Rv903c (PrrA),
and Rv3133c (DevR), were present at lower levels in JAL. L-Al-
anine dehydrogenasewas the first antigen reported to be absent
in theM. bovis BCG (vaccine strain) (18, 64). Two component
systems are studied well in multiple organisms and are known
to coordinate gene expression under different environmental
conditions (65, 66). Most of the target genes of DosR were part
of clusters 4 and 6. Down-regulation of two-component signal-
ing in JALmight suggest a role for two-component signaling in
drug resistance (45). Although the identified sub-clusters only
partially represent the global regulatory perturbations specific
to any strain, a significantly higher flux through the regulatory
network in case of JAL as compared with other three strains is
certainly suggested by the higher magnitude of protein regula-
tion in this strain.
Rv3597c (Lsr2) is considered to be a global transcriptional
regulator that represses a large number of virulence-related
genes (46–48). A recent report has demonstrated the crucial
role of Lsr2 in hypoxia adaptation as well as persistent infection
inside the host (67). In this study most of the Lsr2 targets were
present in clusters 1 and 2 and a few of them in cluster 7. Our
results show the up-regulation of Lsr2 and Rv2989 and down-
regulation of DosR in JAL as comparedwith the other strains. A
corresponding modulation of expression of a number of their
targets was also observed. Although it is tempting to directly
correlate the expression of the target proteins, those of the tran-
scription factors that regulate them, one cannot rule out addi-
tional tiers of regulation.
Cluster 3 contained 17 proteins, which showed low expres-
sion in BND and high expression in all the other three strains.
Interestingly, proteins expressed by the mce1 operon were
found to be down-regulated in the BND strain. The M. tuber-
culosis genome contains four mce operons, thought to be
important for replication in mice (68, 69). The deletion of the
mce1 operon from M. tuberculosis has been shown earlier to
impact the lipid profiles and uptake of palmitic acid and accu-
mulation of more mycolic acids in comparison with the wild
type (40). Cholesterol import andmetabolismare dependent on
the proteins encoded by the mce4 operon (70). We performed
experiments to determine whether this difference would be
reflected in the growth of the strains in different carbon source.
Although we observed slower growth of BND compared with
the other strains in the early stages of growth, the differences in
the growth were nullified when following the growth for a lon-
ger duration (data not shown). One possible explanation for
this phenotype is that, although themce1 operon may be play-
ing a role in adaptation in the early stages of growth in the BND
strain, alternative pathways (other mce operons) may be com-
pensating for the down-regulation of the mce1 operon in the
later stages.
The difference in the virulence between H37Ra and H37Rv
has been largely attributed to a point mutation in the two-com-
ponent system protein PhoP, which is a transcription factor
known to regulate a variety of genes, including the genes in the
esx1 locus (71, 72). Comparison of secreted proteome from
H37Ra andH37Rv using two-dimensional gel followed bymass
spectrometry, showed several proteins with putative ESAT-6
like function to be present at higher levels in H37Rv compared
with H37Ra (73). However, Frigui et al. (72) showed complete
loss of ESAT-6 secretion in the attenuated strain H37Ra. In yet
another study, Malen et al. (74) performed membrane pro-
teomics of H37Ra andH37Rv and did not find lower expression
of ESAT-6 in the membrane fraction. They did observe
decreased expression of several of the PhoP target genes in their
analysis. Interestingly, we did not observe significant differ-
ences in the cellular or secreted levels of ESAT-6 in H37Ra
compared with H37Rv.We followed theMalen et al. (74) strat-
egy and looked at the protein expression levels of PhoP direct
targets.We could find 16 of those genes in our data set, most of
which did not show any significant regulation in either H37Ra
or H37Rv except for two of them (Rv2145c and Rv3881c
(EspB)), which showed significant down-regulation in case or
H37Ra. EspB, a substrate of ESX-1, is known to be required for
virulence and growth in macrophages (75).
The protein members of the ESX-1 family are potent T-cell
antigens that play a critical biological role in interactions with
host cells and are thought to be important for virulence and
pathogenesis (29, 76, 77). Because the ESX-1 machinery is up-
regulated in JAL compared with the other three strains, one
would expect higher levels of ESAT6 and CFP10 proteins in the
culture filtrate fraction. Consistent with the hypothesis that
JAL may have higher ESX-1 activity, we observed higher levels
of ESAT6 and CFP10 in the culture filtrate fraction (Fig. 8, B
and C). In agreement with their proposed role in virulence and
pathogenesis, JAL strain survival in PMA-differentiated THP1
cells was higher than the other strains (Fig. 8D). JAL strain
seems to have the advantage at every time point tested, indicat-
ing that the higher ESX-1 activity may be providing survival
advantage to JAL compared with the other strains. Further-
more, the survival advantage observed seems be dependent on
ESAT-6 levels as pre-incubation with the ESAT-6 antibody sig-
nificantly compromised the intracellular bacterial load (Fig.
8E). Metabolic network analysis (Fig. 6, B and C, and supple-
mental Table 9) revealed that even though a number of proteins
associated with lipid metabolism are down-regulated in JAL,
there was at least one protein-associated -oxidation with each
of the four reactions in the pathway that was up-regulated (see
Fig. 6C). The fact that JAL has alternative pathways for lipid
metabolism and has an efficient ESX-1 secretion system would
explain the survival advantage compared with other strains.
Taken together, the data presented here illustrate the potency
of the proteomic approach to select candidates that are differ-
entially expressed in clinical strains, the relevance of which can
be characterized further using cell andmolecular biology tools.
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